The presence of intralesional fat provides an invaluable tool for narrowing the differential diagnosis for both benign and malignant neoplasms of the abdomen and pelvis. The ability to characterize intralesional fat is further expanded by the ability of magnetic resonance imaging to detect small quantities (intravoxel) of fat. While the presence of intralesional fat can help to provide a relatively narrow set of diagnostic possibilities, depending on the type of fat (macroscopic vs intravoxel) that is present and the organ of origin, radiologists must be aware of uncommon mimickers of pathology, both benign and malignant.
Introduction
Intralesional fat is readily detected at diagnostic imaging, helping to narrow the differential diagnosis and guide clinical management. Intralesional fat can be divided into macroscopic or ''bulk'' fat versus intravoxel fat, where lipid and other soft tissue content coexist within an image voxel. 1 Intravoxel fat may be indicative of a small number of mature adipocytes intermixed with non-lipid-containing cells within the same image voxel or of intracellular fat within lesional cells themselves. 2 Extrahepatic masses containing macroscopic fat are typically well characterized at computed tomography (CT), and the presence of macroscopic fat is often a sign of benignity, with the notable exception of liposarcoma and rare malignant germ cell tumors. Intravoxel fat is better detected at magnetic resonance imaging (MRI) and, while characteristic of benign adrenal adenomas, may also be seen in a variety of malignancies. Occasionally, benign lesions which typically contain macroscopic fat will demonstrate a sufficient paucity of fat content so as to exhibit only intravoxel fat at imaging (eg, angiomyolipoma [AML] or mature teratoma). The differential diagnosis of extrahepatic fat-containing masses of the abdomen and pelvis varies greatly by organ of origin, which is the subject of this review.
Adrenal Gland

Adrenal Adenoma
Adrenal adenomas are the most common benign adrenal neoplasms, the majority of which (60%-90%) are composed of lipid-laden cells (intracellular fat). 3 Diagnostic criteria include attenuation measuring under 10 Hounsfield units (HU) at nonenhanced CT (NECT) or signal drop on opposed-phase T1weighted (T1w) gradient echo (GRE) MRI consistent with intravoxel fat (Figure 1 ). Magnetic resonance imaging may be more sensitive to small quantities of intravoxel fat where CT is indeterminate (10-30 HU). 4 Washout (>40% relative or >60% absolute) on 15-minute versus 60-to 75-second delayed contrast-enhanced CT (CECT) images is also considered diagnostic for an adrenal adenoma and is particularly helpful in the setting of lipid-poor adenomas (>30 HU at NECT). 5 Incidental adrenal masses measuring 1 to 2 cm in size are statistically likely to represent adenomas and can be followed up with an adrenal protocol CT in 12 months, whereas adrenal masses measuring 2 to 4 cm in size warrant further characterization with adrenal protocol CT or MRI to confirm benignity. Stability at 12 months of a small (<4 cm) incidental adrenal mass is suggestive of benignity, even if not meeting strict diagnostic criteria for an adrenal adenoma. 6 Incidental adrenal masses >4 cm without definite benign features warrant surgical assessment, as the likelihood of malignancy increases with size. Caution must be applied in utilizing the presence of intravoxel fat to diagnose a benign adenoma in a patient with known primary malignancy which may contain intralesional fat, such as hepatocellular carcinoma (HCC) or renal cell carcinoma (RCC), which may also mimic adrenal adenomas by washout criteria due to hypervascularity. 7, 8 Additionally, the rare ''collision tumor'' refers to a metastatic adrenal mass superimposed upon and indistinguishable from a preexisting adrenal adenoma. 9 In both cases, lesion heterogeneity (with intravoxel fat demonstrated in only a portion of the mass) and ancillary findings (eg, intermediate to high signal on T2-weighted [T2w] images) may increase the index of suspicion of a malignant lesion, as adrenal adenomas are typically homogeneous lesions with isoto hypointense signal with respect to liver on T2w images. 10, 11 A new or growing adrenal mass should also raise the suspicion of malignancy and warrants further assessment. 6 Finally, pheochromocytoma may mimic adrenal adenomas if washout criteria alone are used for diagnosis. Avidly enhancing (>110-120 HU at 60-to 75-second CECT) or markedly T2 hyperintense lesions should raise the suspicion of pheochromocytoma, and clinical and biochemical (urine/serum metanephrines) correlation should be suggested. 12 
Myelolipoma
Myelolipomas are benign adrenal neoplasms composed of hematopoietic (myelo-) and mature adipocyte (lipo-) elements. 3 They may be composed almost entirely of macroscopic fat (40%; Figure 2 ), mixed soft tissue and fat attenuation/signal (50%), or almost entirely soft tissue (10%-in which case, diagnosis may be challenging). 13 While any quantity of macroscopic fat has classically been considered pathognomonic for a myelolipoma, myelolipomatous metaplasia of an adrenal adenoma or adrenocortical carcinoma (ACC) has rarely been described in lesions containing <10% macroscopic fat. 10, 14 
Adrenocortical Carcinoma
Adrenocortical carcinoma, like HCC and RCC, may contain foci of intravoxel fat. 15, 16 Typically, ACC are large (>4 cm) at presentation; and other signs which may be suggestive of malignancy include heterogeneous enhancement, invasive pattern of growth, or distant metastases. 3 
Kidney
Renal Cell Carcinoma
Renal cell carcinoma is the most common primary renal malignancy, accounting for approximately 70% of cases. Clear cell RCC is the most common variant and may demonstrate intravoxel fat due to high lipid content of tumor cells. 17 While intravoxel lipid can also be seen in fat-poor AMLs, clear cell RCC typically demonstrates heterogeneously intermediate to high signal intensity on T2w sequences, whereas fat-poor AMLs typically demonstrate homogeneously low signal intensity on T2w imaging. 18 Rarely, RCC may contain foci of macroscopic fat, mimicking an AML. This may occur secondary to engulfment of the adjacent renal sinus fat or due to osseous metaplasia, where the fat is thought to be related to marrow elements. 19 Macroscopic fat-containing RCCs without renal sinus involvement have almost always been described in the presence of intralesional calcification, and this finding should raise the index of suspicion. 20 As with ACC, large size, an invasive pattern of growth, or distant metastases may further suggest a malignant etiology. 19 
Renal AMLs
Renal AMLs are composed of vascular, smooth muscle, and mature adipocyte elements. Approximately 20% of AMLs occur in the context of tuberous sclerosis, occurring in 75% to 80% of patients with tuberous sclerosis by their second decade, usually multiple and bilateral ( Figure 3 ). 17, 21 The presence of macroscopic fat in the absence of intralesional calcification is felt to be reliably diagnostic for an AML, despite the rare exception of noncalcified fat-containing RCC reported in the case literature. 20, 22 Renal AMLs may contain variable quantities of fat, and if no discernable macroscopic fat is identifiable at CT, then diagnosis may be challenging. Magnetic resonance imaging may help in further characterizing fat-poor AMLs by demonstrating signal drop on opposed-phase T1w GRE images due to small amounts of microscopic fat (mature adipocytes intermixed with vascular and smooth muscle elements within the same voxel). 22 Ancillary findings may then be used to distinguish fat-poor AMLs from an RCC. Clear cell RCC, as described above, may contain intravoxel fat but typically demonstrates iso-to hyperintense signal at T2w imaging; and papillary RCC, which may demonstrate similar hypointense signal on T2w imaging to an AML, will uncommonly contain fat and appears more heterogeneous and progressively enhancing than a fat-poor AML. 18 
Urinary Bladder
Bladder Wall Lipoma
Bladder wall lipomas are rare circumscribed homogeneously macroscopic fat-containing lesions arising from the suburothelial layers of the urinary bladder wall. Their description is limited to case literature. 23 
Suburothelial Fat Deposition
Deposition of nonencapsulated macroscopic fat within the suburothelial layers of the urinary bladder is a common and likely incidental finding (Figure 4) , with male predominance. 24, 25 At histopathology, mature adipose tissue is present in the bladder wall in up to 53% of cystectomy specimens, with detectable suburothelial macroscopic fat described in up to 15% of patients at CT or MRI. 25, 26 Reproductive Organs
Lipoleiomyoma
Lipoleiomyomas are rare benign mesenchymal tumors of the uterus, a variant of leiomyoma composed of smooth muscle, mature adipocytes, and fibrous tissue. 27 At imaging, lipoleiomyomas resemble leiomyomas, presenting as a wellcircumscribed masses which may be submucosal, intramural, or subserosal in location; however, they contain variable quantities of macroscopic fat ( Figure 5 ). 
Mature Teratoma
Mature teratomas are benign germ cell neoplasms of the ovary characterized by the presence of macroscopic fat. They typically appear heterogeneously hyperechoic on ultrasound ( Figure 6 ) with posterior acoustic shadowing (''tip of the iceberg'' sign). On CT, their appearance may vary from a cystic mass with fat-fluid level-with or without a high-density Rokitansky nodule composed of other soft tissue elements floating at the interface-to a predominantly solid mass with macroscopic fat density (Figure 7 ). MRI will also demonstrate findings of macroscopic fat. 28 Mature teratomas without discernable macroscopic fat are rare, in which case MRI may be helpful in detecting smaller amounts of microscopic fat through signal drop on opposed-phase T1w GRE images (Figure 8) . 29, 30 Malignant transformation is rare (<1%), usually to squamous cell carcinoma. 31
Immature Teratoma
Immature teratomas are rare (<1% of teratomas) malignant germ cell neoplasms of the ovary. 32 Like mature teratomas, they typically will contain foci of macroscopic fat; however, they are typically larger and more heterogeneous at presentation with greater solid-enhancing component and less pronounced component of fat ( Figure 9 ). 33, 34 Invasive, rapid pattern of growth or distant metastases are also findings suggestive of malignancy.
Spermatic Cord Lipoma
Spermatic cord lipomas are benign lesions composed of mature adipose tissue and are the most common extratesticular neoplasm ( Figure 10 ). Unlike inguinal hernias, they have no connection to the intraperitoneal fat. 35 
Gastrointestinal Tract
Lipoma
Lipomas are circumscribed lesions composed of mature adipose tissue and may occur anywhere along the gastrointestinal tract.
While they are submucosal-based lesions, they may appear at imaging to be entirely intraluminal ( Figure 11 ). Usually asymptomatic, they may occasionally present with complications related to ulceration or intussusception, particularly when larger. 36 
Submucosal Fat Deposition
Deposition of macroscopic fat within the submucosal layers of the bowel wall was previously felt to be a pathognomonic sequela of chronic bowel inflammation in the context of inflammatory bowel disease ( Figure 12 ). However, more recent data suggest that this is a more common finding, which in the absence of a clinical history compatible with bowel inflammation, may be a variant of normal or related to obesity. 37 Retroperitoneum, Peritoneum, and Mesentery
Atypical Lipomatous Tumors/Liposarcoma
Primary lipomas of the retroperitoneum are exceedingly rare, and circumscribed simple-appearing masses of the retroperitoneum composed of macroscopic fat are more likely to represent a well-differentiated liposarcoma/atypical lipomatous tumor ( Figure 13 ). 38 While these may occur anywhere in the abdominal cavity, the retroperitoneum is the most common location. 39 Greater complexity, invasive or rapid growth, or distant metastases must raise the suspicion of a more aggressive malignancy.
Omental Infarct/Epiploic Appendagitis
Omental infarct and epiploic appendagitis are inflammatory conditions which may simulate a fat-containing mass in the peritoneal cavity. They are secondary to torsion and devascularization of a portion of the omental fat or of a colonic epiploic appendage, respectively, typically presenting with acute abdominal pain. 40 Omental infarcts classically present as large (>5 cm), encapsulated macroscopic fat-containing masses with surrounding edema/inflammatory change ( Figure  14) , most commonly within the right hemiabdomen adjacent to the ascending colon. 41 At CT, epiploic appendagitis usually presents as an ovoid encapsulated macroscopic fat density mass with surrounding inflammatory stranding, most commonly within the left lower quadrant adjacent to the sigmoid colon. 42 A central focus of hyperdensity (''central dot'' sign) may be seen and is thought to represent the thrombosed vascular pedicle ( Figure 15 ). Management of both conditions is conservative with anti-inflammatory medication.
Peritoneal Metastases
Occasionally, confluent peritoneal metastases may encapsulate peritoneal fat, resulting in a mixed fat and soft-tissue conglomeration which may mimic other benign (eg, omental infarct) or malignant (eg, liposarcoma) etiologies ( Figure 16 ). An inflammatory-appearing peritoneal mass with greater complexity than expected of an omental infarct and in the absence of acute clinical symptoms should be viewed with a high index of suspicion.
Summary
The presence of intralesional fat provides an invaluable tool for narrowing the differential diagnosis for both benign and malignant neoplasms of the abdomen and pelvis. The ability to characterize intralesional fat is further expanded by the ability of MRI to detect small quantities (intravoxel) of fat. However, despite a relatively narrow range of common diagnostic considerations, radiologists must be mindful of atypical findings which may suggest a more aggressive albeit rare etiology (eg, macroscopic fat-containing RCC or immature teratoma) as well as inflammatory conditions which may simulate a focal mass.
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